Filter
1153
Filtered Results: 1153
Text search:
pharmaceutical
manufacturers
Featured
Recommendations
110
New Publications
283
Language
Document type
No document type
517
Studies & Reports
246
Guidelines
199
Manuals
81
Strategic & Response Plan
61
Fact sheets
20
Training Material
14
Situation Updates
8
Brochures
3
Resource Platforms
3
Infographics
1
Countries / Regions
Global
55
India
44
Kenya
40
Western and Central Europe
31
Ethiopia
28
Nigeria
26
Ghana
18
South Africa
18
Sierra Leone
15
Uganda
15
Ukraine
14
Zimbabwe
14
Bangladesh
14
Nepal
13
Malawi
13
Philippines
13
Africa
13
Tanzania
13
Rwanda
12
Latin America and the Carribbean
12
Eastern Europe
12
Zambia
12
Namibia
11
South–East Asia Region
10
Eastern Europe and Central Asia
8
Eswatini/ Swaziland
8
Syria
7
Indonesia
7
Liberia
7
Myanmar / Burma
7
West and Central Africa
6
Botswana
6
Thailand
5
East and Southern Africa
5
Senegal
4
Cambodia
4
Burkina Faso
3
USA
3
Haiti
3
Asia
3
Middle East and North Africa
3
Western Pacific Region
3
Vietnam
3
Egypt
3
North Macedonia
2
Serbia
2
Lesotho
2
Benin
2
China
2
Cameroon
2
Albania
2
Laos
2
Kyrgyzstan
2
Jordan
2
Germany
2
Congo, Democratic Republic of
2
North America
2
Jamaica
2
United Kingdom
2
Lebanon
2
Russia
2
Sudan
2
Tajikistan
1
Timor Leste/ East Timor
1
Australia
1
Kazakhstan
1
Chile
1
Iran
1
Fiji
1
Uzbekistan
1
Afghanistan
1
Mongolia
1
Bulgaria
1
Guinea
1
Mozambique
1
Armenia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Maldives
1
Papua New Guinea
1
Moldova
1
Georgia
1
Mali
1
Libya
1
South Sudan
1
Iraq
1
Somalia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
385
Clinical Guidelines
104
Public Health
67
Key Resources
59
Women & Child Health
39
Pharmacy & Technologies
36
Capacity Building
7
Toolboxes
AMR
137
Pharmacy
132
COVID-19
81
TB
56
Mental Health
55
HIV
53
Rapid Response
48
NTDs
33
Planetary Health
27
Caregiver
26
Global Health Education
25
NCDs
22
Conflict
22
Health Financing Toolbox
20
Malaria
15
Specific Hazards
12
Ebola & Marburg
10
Polio
8
Refugee
7
Disability
7
Natural Hazards
4
Zika
2
Cholera
1
Social Ethics
1
16.7.2021
Attention-Deficit/Hyperactivity Disorder
In light of the decline in new Ebola cases, strategies are now needed to scale down the activities and bed capacities in Ebola care facilities. These facilities include Ebola treatment units, community care centres, Ebola treatment centres and isolation centres. The Governments of Guinea, Liberia an...
Malar J (2017) 16:174 DOI 10.1186/s12936-017-1808-x
Background: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatment for uncomplicated malaria in Benin. In 2016, a medicine outlet survey was implemented to investigate the availability, price, and market share of...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...
In aquaculture, antibiotics have been used mainly for therapeutic purposes and as prophylactic agents. The contribution to antimicrobial resistance of antibiotics used in aquaculture is reviewed here, using a risk analysis framework. Some recommendations on responsible conduct in this context are pr...
Accessed 15th of October 2015
The Agency for Toxic Substances and Disease Registry (ATSDR) has produced a three-volume series entitled Managing Hazardous Material Incidents. The series is designed to help emergency response and health care professionals plan for and respond to hazardous material emergencies.
- Volume I Emergenc...
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
This working paper aims to provide a rough over-view of existing rules and guidelines on the coopera-tion between the UN and the private sector – at least as they are publicly available. It will describe com-mon features and discuss advances and shortcomings of the most prominent a...
This report has been developed, based on data provided by the TB & ORD surveillance system from across Rwanda. It provides a comprehensive picture of the occurrence and management of TB & ORD and Leprosy in Rwanda. It is structured based on the 2013-2018 Rwanda TB national strategic plan (2013-2018 ...
Guidelines for Good Clinical Laboratory Practices (GCLP) outlines the principles and procedures to be followed by medical laboratories involved in clinical research and/or patient care so as to provide quality data which can be used for health research and patient treatment. As the use of laboratory...
In Vietnam, most of the examination and treatment facilities are facing with of spread of bacteria resistant to many antibiotics. The level and speed of drug resistance are increasing, at alarming level. The burden of drug resistance is increasing due to the increasing cost of treatment, prolonged t...
The unparalleled action needed to combat unprecedented inequality in the wake of COVID-19.
New billionaire minted every 26 hours, as inequality contributes to the death of one person every four seconds
Available in English, French, Spanish and Arabic https://www.oxfam.org/en/research/inequality-ki...
This brochure presents a summary of the situation of health systems and services in the Americas as they progress toward the achievement of universal access to health and universal health coverage (universal health). The information provided presents an overview of the situation before the COVID-19 ...
Cardiovascular diseases (CVDs) are a growing public health problem in Ghana and other African countries. Strokes and other CVDs have become a leading cause of death due to increasing risk factors such as hypertension. According to the Global Burden of Disease study (GBD), ischaemic heart disease was...
The objectives of NAP are aligned with the global action plan based on national needs and priorities. The emphasis is on One Health approach with all sectors especially human health, animal health and environment contributing towards minimizing the emergence and impact of AMR in Jordan.
